Description
Recombinant monoclonal antibody to human TL1A. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma MDRH2. This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
human TL1A
Target Alias Names
TL1, TNF-like ligand 1A, Tumor necrosis factor superfamily member 15, TNF superfamily member 15, TNFSF15, Vascular endothelial growth inhibitor, VEGI, VEGI192A, TNLG1B
Isotype/Mimetic
IgG
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression